Advisor Partners LLC Amgen Inc Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Advisor Partners LLC holds 23,677 shares of AMGN stock, worth $7.47 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

23,677

Previous 22,031 7.47%

Holding current value

$7.47 Million

Previous $5.33 Million 8.15%

% of portfolio

0.41%

Previous 0.33%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $379,748 - $422,594	1,646 Added 7.47%	23,677 $5.76 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $294,479 - $325,771	1,343 Added 6.49%	22,031 $5.33 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $227,518 - $260,374	-1,144 Reduced 5.24%	20,688 $4.66 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $593,931 - $695,862	-2,798 Reduced 11.36%	21,832 $4.64 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $77,782 - $86,293	-333 Reduced 1.33%	24,630 $6 Million
Q1 2021 Jun 01, 2021	SELL	$221.91 - $258.6 $432,946 - $504,528	-1,951 Reduced 7.25%	24,963 $6.21 Million
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $281,943 - $335,744	-1,303 Reduced 4.62%	26,914 $6.19 Million
Q3 2020 Nov 19, 2020	BUY	$234.65 - $260.95 $26,750 - $29,748	114 Added 0.41%	28,217 $7.17 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $108,399 - $133,021	548 Added 1.99%	28,103 $6.63 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.29 Million - $1.71 Million	7,060 Added 34.45%	27,555 $5.59 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $257,514 - $330,995	1,361 Added 7.11%	20,495 $4.95 Million
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $352,398 - $422,246	2,024 Added 11.83%	19,134 $3.7 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $479,095 - $561,608	-2,874 Reduced 14.38%	17,110 $3.15 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $265,517 - $299,295	1,468 Added 7.93%	19,984 $3.8 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $247,797 - $289,259	1,389 Added 8.11%	18,516 $3.61 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $105,244 - $118,649	568 Added 3.43%	17,127 $3.55 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $98,467 - $110,600	593 Added 3.71%	16,559 $3.06 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $220,428 - $257,598	1,301 Added 8.87%	15,966 $2.72 Million
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $197,821 - $221,027	1,172 Added 8.69%	14,665 $2.78 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $2.26 Million - $2.58 Million	13,493	13,493 $2.52 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Amgen Inc Transaction History